X

Xilio Therapeutics Inc
NASDAQ:XLO

Watchlist Manager
Xilio Therapeutics Inc
NASDAQ:XLO
Watchlist
Price: 0.7052 USD 1.47%
Market Cap: 37m USD

Operating Margin
Xilio Therapeutics Inc

-137.6%
Current
-484%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-137.6%
=
Operating Profit
-43.8m
/
Revenue
31.8m

Operating Margin Across Competitors

No Stocks Found

Xilio Therapeutics Inc
Glance View

Market Cap
36.5m USD
Industry
Biotechnology

Xilio Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in Waltham, Massachusetts and currently employs 74 full-time employees. The company went IPO on 2021-10-22. The firm has built its geographically precise solutions (GPS) platform to rapidly engineer molecules, including cytokines and other biologics. The Company’s most advanced product candidates are in clinical development. Its XTX101 is a clinical-stage, tumor-selective anti-CTLA-4 mAb, which is designed to improve upon the therapeutic index of existing anti-CTLA-4 therapies by localizing its activity in the TME. The company initiated a Phase I/II trial to evaluate XTX101 in patients with advanced solid tumors, and enrollment is ongoing. XTX202 is an engineered form of IL-2, which is masked with a protein domain to prevent binding activity until the protein domain is cleaved off by TME-associated proteases. The company initiated a Phase I/II trial to evaluate XTX202 in patients with solid tumors.

XLO Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-137.6%
=
Operating Profit
-43.8m
/
Revenue
31.8m
What is the Operating Margin of Xilio Therapeutics Inc?

Based on Xilio Therapeutics Inc's most recent financial statements, the company has Operating Margin of -137.6%.

Back to Top